Frazier Healthcare Partners has acquired behavioral health pharmacy platform Altruix from WindRose Health Investors.
Headquartered in Hunt Valley, Md., Altruix is a behavioral health pharmacy platform serving patients with severe mental illness, substance use disorders, and intellectual and developmental disabilities. WindRose Health Investors initially invested in the company, then operating as Terrapin Pharmacy, in December 2021. Altruix provides high-touch pharmacy services, care coordination and access to specialty and limited-distribution drugs aimed at improving outcomes and lowering costs for patients, providers, payors and pharmaceutical partners.
Houlihan Lokey and Cantor Fitzgerald acted as financial advisors to WindRose, while Latham & Watkins served as legal advisor. Goodwin Procter acted as legal advisor to Frazier Healthcare Partners.